SEC Tracker
Get the app

Altimmune ALT

Altimmune reports stock transactions

Christophe Arbet-Engels, insider filing for ALT

Form
4
Filed
Importance
Routine
  1. Oct 1, 2026 - 37,500 common shares acquired
  2. Oct 1, 2026 - 12,679 common shares disposed
  3. RSUs vesting over 4 years with 25% on Oct 1, 2026

Written from the Form 4 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Altimmune files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Prothena Corp Public PRTA public float $327M, Jun 30, 2025
  2. Usana Health Sciences USNA public float $328M, Jun 27, 2025
  3. Rigel Pharmaceuticals RIGL public float $332M, Jun 30, 2025
  4. Aura Biosciences AURA public float $321M, Jun 30, 2025
  5. Amarin AMRN public float $335M, Jun 30, 2025